Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Progress in Vaccine-Preventable and Respiratory Infectious Diseases-First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006-2015.

Schuchat A, Anderson LJ, Rodewald LE, Cox NJ, Hajjeh R, Pallansch MA, Messonnier NE, Jernigan DB, Wharton M.

Emerg Infect Dis. 2018 Jul;24(7):1178-1187. doi: 10.3201/eid2407.171699.

2.

The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.

Samai M, Seward JF, Goldstein ST, Mahon BE, Lisk DR, Widdowson MA, Jalloh MI, Schrag SJ, Idriss A, Carter RJ, Dawson P, Kargbo SAS, Leigh B, Bawoh M, Legardy-Williams J, Deen G, Carr W, Callis A, Lindblad R, Russell JBW, Petrie CR, Fombah AE, Kargbo B, McDonald W, Jarrett OD, Walker RE, Gargiullo P, Bash-Taqi D, Gibson L, Fofanah AB, Schuchat A; STRIVE Study Team.

J Infect Dis. 2018 May 18;217(suppl_1):S6-S15. doi: 10.1093/infdis/jiy020. Erratum in: J Infect Dis. 2018 Jul 2;218(3):508-507.

3.

Comment: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).

Schuchat A, Seward JF, Goldstein ST, Mahon BE.

J Infect Dis. 2018 May 18;217(suppl_1):S1-S5. doi: 10.1093/infdis/jix665. No abstract available.

4.

Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak: Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Carter RJ, Idriss A, Widdowson MA, Samai M, Schrag SJ, Legardy-Williams JK, Estivariz CF, Callis A, Carr W, Webber W, Fischer ME, Hadler S, Sahr F, Thompson M, Greby SM, Edem-Hotah J, Momoh RM, McDonald W, Gee JM, Kallon AF, Spencer-Walters D, Bresee JS, Cohn A, Hersey S, Gibson L, Schuchat A, Seward JF.

J Infect Dis. 2018 May 18;217(suppl_1):S16-S23. doi: 10.1093/infdis/jix657.

5.

The End of Human Papillomavirus Vaccine Exceptionalism.

Schuchat A.

Acad Pediatr. 2018 Mar;18(2S):S17-S18. doi: 10.1016/j.acap.2017.04.022. No abstract available.

PMID:
29502630
6.

Prescription Drug Monitoring Programs and Opioid Death Rates-Reply.

Schuchat A, Guy GP Jr, Dowell D.

JAMA. 2017 Nov 28;318(20):2045. doi: 10.1001/jama.2017.16304. No abstract available.

PMID:
29183067
7.

New Data on Opioid Use and Prescribing in the United States.

Schuchat A, Houry D, Guy GP Jr.

JAMA. 2017 Aug 1;318(5):425-426. doi: 10.1001/jama.2017.8913. No abstract available.

8.

Improving the Health of the United States With a "Winnable Battles" Initiative.

Frieden TR, Ethier K, Schuchat A.

JAMA. 2017 Mar 7;317(9):903-904. doi: 10.1001/jama.2017.0436. No abstract available.

PMID:
28152127
9.

The CDC's Recommendations to Help Prevent Fetal Alcohol Spectrum Disorders.

Schuchat A.

Am Fam Physician. 2017 Jan 1;95(1):6-7. No abstract available.

10.

Zika Virus 6 Months Later.

Frieden TR, Schuchat A, Petersen LR.

JAMA. 2016 Oct 11;316(14):1443-1444. doi: 10.1001/jama.2016.11941. No abstract available.

PMID:
27532277
11.

Implementing an Ebola Vaccine Study - Sierra Leone.

Widdowson MA, Schrag SJ, Carter RJ, Carr W, Legardy-Williams J, Gibson L, Lisk DR, Jalloh MI, Bash-Taqi DA, Kargbo SA, Idriss A, Deen GF, Russell JB, McDonald W, Albert AP, Basket M, Callis A, Carter VM, Ogunsanya KR, Gee J, Pinner R, Mahon BE, Goldstein ST, Seward JF, Samai M, Schuchat A.

MMWR Suppl. 2016 Jul 8;65(3):98-106. doi: 10.15585/mmwr.su6503a14.

PMID:
27387395
12.

Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era.

Schuchat A, Fiebelkorn AP, Bellini W.

Microbiol Spectr. 2016 Apr;4(2). doi: 10.1128/microbiolspec.EI10-0006-2015. Review.

PMID:
27227293
13.

Pneumococcal Prevention Gets Older and Wiser.

Schuchat A.

JAMA Intern Med. 2015 Dec;175(12):1897-8. doi: 10.1001/jamainternmed.2015.6133. Review. No abstract available.

14.

Cultivation of an Adaptive Domestic Network for Surveillance and Evaluation of Emerging Infections.

Pinner RW, Lynfield R, Hadler JL, Schaffner W, Farley MM, Frank ME, Schuchat A.

Emerg Infect Dis. 2015 Sep;21(9):1499-509. doi: 10.3201/eid2109.150619.

15.

HPV "coverage".

Schuchat A.

N Engl J Med. 2015 Feb 19;372(8):775-6. doi: 10.1056/NEJMe1415742. No abstract available.

16.

Measles in our time: the US experience.

Schuchat A.

Future Virol. 2015;10(7):1-4. doi: 10.2217/fvl.15.54. Epub 2015 Jul 20. No abstract available.

17.

Global health and the US Centers for Disease Control and Prevention.

Schuchat A, Tappero J, Blandford J.

Lancet. 2014 Jul 5;384(9937):98-101. No abstract available.

PMID:
24998008
18.

First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014.

Bialek SR, Allen D, Alvarado-Ramy F, Arthur R, Balajee A, Bell D, Best S, Blackmore C, Breakwell L, Cannons A, Brown C, Cetron M, Chea N, Chommanard C, Cohen N, Conover C, Crespo A, Creviston J, Curns AT, Dahl R, Dearth S, DeMaria A, Echols F, Erdman DD, Feikin D, Frias M, Gerber SI, Gulati R, Hale C, Haynes LM, Heberlein-Larson L, Holton K, Ijaz K, Kapoor M, Kohl K, Kuhar DT, Kumar AM, Kundich M, Lippold S, Liu L, Lovchik JC, Madoff L, Martell S, Matthews S, Moore J, Murray LR, Onofrey S, Pallansch MA, Pesik N, Pham H, Pillai S, Pontones P, Pringle K, Pritchard S, Rasmussen S, Richards S, Sandoval M, Schneider E, Schuchat A, Sheedy K, Sherin K, Swerdlow DL, Tappero JW, Vernon MO, Watkins S, Watson J; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 May 16;63(19):431-6. Erratum in: MMWR Morb Mortal Wkly Rep. 2014 Jun 27;63(25):554.

19.

Benefits from immunization during the vaccines for children program era - United States, 1994-2013.

Whitney CG, Zhou F, Singleton J, Schuchat A; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Apr 25;63(16):352-5.

20.

Progress towards demonstrating the impact of Haemophilus influenzae type b conjugate vaccines globally.

Hajjeh R, Mulholland K, Schuchat A, Santosham M.

J Pediatr. 2013 Jul;163(1 Suppl):S1-3. doi: 10.1016/j.jpeds.2013.03.022. No abstract available.

21.

The state of immunization 2013: we are the world.

Schuchat A.

S D Med. 2013;Spec no:27-32. Review.

PMID:
23444588
22.

Protecting adults from influenza: tis the season to learn from the pandemic.

Schuchat A, Katz JM.

J Infect Dis. 2012 Sep 15;206(6):803-5. doi: 10.1093/infdis/jis428. Epub 2012 Jul 10. No abstract available.

PMID:
22782951
23.

The value of science in integration of services.

Schuchat A, De Cock KM.

J Infect Dis. 2012 Mar;205 Suppl 1:S1-3. doi: 10.1093/infdis/jir801. No abstract available.

PMID:
22315376
24.

Vaccine-preventable diseases, immunizations, and the Epidemic Intelligence Service.

Hinman AR, Orenstein WA, Schuchat A.

Am J Epidemiol. 2011 Dec 1;174(11 Suppl):S16-22. doi: 10.1093/aje/kwr306.

PMID:
22135390
25.

Vaccine-preventable diseases, immunizations, and MMWR--1961-2011.

Hinman AR, Orenstein WA, Schuchat A; Centers for Disease Control and Prevention (CDC).

MMWR Suppl. 2011 Oct 7;60(4):49-57. No abstract available.

PMID:
21976166
26.

Bacterial meningitis in the United States, 1998-2007.

Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL, Harrison LH, Farley MM, Reingold A, Bennett NM, Craig AS, Schaffner W, Thomas A, Lewis MM, Scallan E, Schuchat A; Emerging Infections Programs Network.

N Engl J Med. 2011 May 26;364(21):2016-25. doi: 10.1056/NEJMoa1005384.

27.

Reflections on pandemics, past and present.

Schuchat A.

Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S4-6. doi: 10.1016/j.ajog.2011.02.039. Epub 2011 Feb 22.

PMID:
21419383
28.

The science behind preparing and responding to pandemic influenza: the lessons and limits of science.

Schuchat A, Bell BP, Redd SC.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S8-12. doi: 10.1093/cid/ciq007. Review.

PMID:
21342904
29.

Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010).

Shrestha SS, Swerdlow DL, Borse RH, Prabhu VS, Finelli L, Atkins CY, Owusu-Edusei K, Bell B, Mead PS, Biggerstaff M, Brammer L, Davidson H, Jernigan D, Jhung MA, Kamimoto LA, Merlin TL, Nowell M, Redd SC, Reed C, Schuchat A, Meltzer MI.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S75-82. doi: 10.1093/cid/ciq012.

PMID:
21342903
30.

Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults.

Burton DC, Flannery B, Bennett NM, Farley MM, Gershman K, Harrison LH, Lynfield R, Petit S, Reingold AL, Schaffner W, Thomas A, Plikaytis BD, Rose CE Jr, Whitney CG, Schuchat A; Active Bacterial Core Surveillance/Emerging Infections Program Network.

Am J Public Health. 2010 Oct;100(10):1904-11. doi: 10.2105/AJPH.2009.181313. Epub 2010 Aug 19.

31.

Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization.

Cohen AL, Harrison LH, Farley MM, Reingold AL, Hadler J, Schaffner W, Lynfield R, Thomas AR, Campsmith M, Li J, Schuchat A, Moore MR; Active Bacterial Core Surveillance Team.

AIDS. 2010 Sep 10;24(14):2253-62. doi: 10.1097/QAD.0b013e32833d46fd.

PMID:
20671543
32.

Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.

Hajjeh RA, Privor-Dumm L, Edmond K, O'Loughlin R, Shetty S, Griffiths UK, Bear AP, Cohen AL, Chandran A, Schuchat A, Mulholland EK, Santosham M.

Vaccine. 2010 Oct 8;28(43):7123-9. doi: 10.1016/j.vaccine.2010.07.028. Epub 2010 Jul 24.

PMID:
20659515
33.

1918 and 2009: a tale of two pandemics.

Redd SC, Frieden TR, Schuchat A, Briss PA.

Public Health Rep. 2010 Apr;125 Suppl 3:3-5. No abstract available.

34.

Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use.

Pilishvili T, Zell ER, Farley MM, Schaffner W, Lynfield R, Nyquist AC, Vazquez M, Bennett NM, Reingold A, Thomas A, Jackson D, Schuchat A, Whitney CG.

Pediatrics. 2010 Jul;126(1):e9-17. doi: 10.1542/peds.2009-2150. Epub 2010 Jun 14.

PMID:
20547641
35.

Estimating the vaccine-preventable burden of hospitalized pneumonia among young Mozambican children.

Roca A, Sigaúque B, Quintó L, Morais L, Berenguera A, Corachan M, Ribó JL, Naniche D, Bassat Q, Sacoor Ch, Nhalungo D, Macete E, Schuchat A, Soriano-Gabarró M, Flannery B, Alonso PL.

Vaccine. 2010 Jul 5;28(30):4851-7. doi: 10.1016/j.vaccine.2010.03.060. Epub 2010 Apr 12.

PMID:
20392430
36.

Preventing complications from 2009 influenza A (H1N1) in persons with underlying lung diseases: a formidable challenge for 2010 Year of the Lung.

Castro KG, Bell BP, Schuchat A.

Int J Tuberc Lung Dis. 2010 Feb;14(2):127-9. No abstract available.

PMID:
20074400
37.

Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial.

Cutland CL, Madhi SA, Zell ER, Kuwanda L, Laque M, Groome M, Gorwitz R, Thigpen MC, Patel R, Velaphi SC, Adrian P, Klugman K, Schuchat A, Schrag SJ; PoPS Trial Team.

Lancet. 2009 Dec 5;374(9705):1909-16. doi: 10.1016/S0140-6736(09)61339-8. Epub 2009 Oct 19.

PMID:
19846212
38.

Evaluation of universal antenatal screening for group B streptococcus.

Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, Mohle-Boetani J, Gershman K, Schaffner W, Petit S, Zansky SM, Morin CA, Spina NL, Wymore K, Harrison LH, Shutt KA, Bareta J, Bulens SN, Zell ER, Schuchat A, Schrag SJ.

N Engl J Med. 2009 Jun 18;360(25):2626-36. doi: 10.1056/NEJMoa0806820.

39.

Severe pneumonia in Mozambican young children: clinical and radiological characteristics and risk factors.

Sigaúque B, Roca A, Bassat Q, Morais L, Quintó L, Berenguera A, Machevo S, Bardaji A, Corachan M, Ribó J, Menéndez C, Schuchat A, Flannery B, Soriano-Gabarró M, Alonso PL.

J Trop Pediatr. 2009 Dec;55(6):379-87. doi: 10.1093/tropej/fmp030. Epub 2009 Apr 28.

PMID:
19401405
40.

Early experience with human papillomavirus vaccine introduction in the United States, Canada and Australia.

Shefer A, Markowitz L, Deeks S, Tam T, Irwin K, Garland SM, Schuchat A.

Vaccine. 2008 Aug 19;26 Suppl 10:K68-75. doi: 10.1016/j.vaccine.2008.05.065. Review.

PMID:
18847559
41.

Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998--2003.

Teshale EH, Hanson D, Flannery B, Phares C, Wolfe M, Schuchat A, Sullivan P.

Vaccine. 2008 Oct 29;26(46):5830-4. doi: 10.1016/j.vaccine.2008.08.032. Epub 2008 Sep 9.

PMID:
18786586
42.

Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.

Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, Stefonek KR, Albanese BA, Zell ER, Schuchat A, Schrag SJ; Active Bacterial Core surveillance/Emerging Infections Program Network.

JAMA. 2008 May 7;299(17):2056-65. doi: 10.1001/jama.299.17.2056.

PMID:
18460666
43.

Monitoring the impact of vaccines postlicensure: new challenges, new opportunities.

Schuchat A, Bell BP.

Expert Rev Vaccines. 2008 May;7(4):437-56. doi: 10.1586/14760584.7.4.437. Review.

PMID:
18444891
44.

Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children.

Park SY, Moore MR, Bruden DL, Hyde TB, Reasonover AL, Harker-Jones M, Rudolph KM, Hurlburt DA, Parks DJ, Parkinson AJ, Schuchat A, Hennessy TW.

Pediatr Infect Dis J. 2008 Apr;27(4):335-40. doi: 10.1097/INF.0b013e318161434d.

PMID:
18316986
45.

Invasive group-A streptococcal infection in an allograft recipient. A case report.

Lee EH, Ferguson D, Jernigan D, Greenwald M, Coté T, Bos JE, Guarner J, Zaki S, Schuchat A, Beall B, Srinivasan A.

J Bone Joint Surg Am. 2007 Sep;89(9):2044-7. No abstract available.

PMID:
17768205
46.

Risk factors for invasive pneumococcal disease among Navajo adults.

Watt JP, O'Brien KL, Benin AL, McCoy SI, Donaldson CM, Reid R, Schuchat A, Zell ER, Hochman M, Santosham M, Whitney CG.

Am J Epidemiol. 2007 Nov 1;166(9):1080-7. Epub 2007 Aug 9.

PMID:
17693393
47.

The use of chlorhexidine to reduce maternal and neonatal mortality and morbidity in low-resource settings.

McClure EM, Goldenberg RL, Brandes N, Darmstadt GL, Wright LL; CHX Working Group, Armbruster D, Biggar R, Carpenter J, Free MJ, Mattison D, Mathai M, Moss N, Mullany LC, Schrag S, Tielsch J, Tolosa J, Wall SN, Schuchat A, Smine A.

Int J Gynaecol Obstet. 2007 May;97(2):89-94. Epub 2007 Mar 30. Review.

48.

Perinatal group B streptococcal disease.

Heath PT, Schuchat A.

Best Pract Res Clin Obstet Gynaecol. 2007 Jun;21(3):411-24. Epub 2007 Mar 2. Review.

PMID:
17336588
49.

From pandemic suspect to the postvaccine era: the Haemophilus influenzae story.

Schuchat A, Messonnier NR.

Clin Infect Dis. 2007 Mar 15;44(6):817-9. Epub 2007 Feb 1. No abstract available.

PMID:
17304453
50.

Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa.

von Gottberg A, de Gouveia L, Madhi SA, du Plessis M, Quan V, Soma K, Huebner R, Flannery B, Schuchat A, Klugman K.

Bull World Health Organ. 2006 Oct;84(10):811-8.

Supplemental Content

Loading ...
Support Center